Mandana Khalili

Mandana Khalili, MD is a Researcher at the University of California San Francisco (UCSF) with affiliations to the UCSF Liver Center and Philip R. Lee Institute for Health Policy Studies. Her work focuses on hepatology with emphasis on health disparities, viral hepatitis, and HIV/hepatitis coinfection in vulnerable populations.

• Education: Masters in Advanced Studies in Clinical and Epidemiologic Research (UCSF, 2005), Transplant Hepatology Fellowship (UCSF, 1999), Medical Degree (McGill University, 1992)

Dr. Khalili's research explores hepatocellular carcinoma surveillance, steatotic liver disease management, and telemedicine applications in underserved communities. Her 15 most recent publications (2022-2025) examine topics like HBV/HIV coinfection, alcohol-related liver disease, and culturally tailored interventions for Latino/Asian populations.

Notable scientific awards include the UCSF Mentoring Award (2024), Zuckerberg SF Clinical Service Recognition (2022), and NIH Mid-Career Investigator Award (2014). She served as Visiting Professor in China (2019) and Hepatitis B Research Network member since 2018, with significant contributions to global hepatitis C elimination and immunotolerant HBV therapy research.